ArticleJournal of experimental & clinical cancer research : CR2022

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients.

Marianna Buttarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.